MARIA REED: Open Payments
NPI 1629082482 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 45 payments from 15 companies in 2025. Trend: 2023 $982 · 2024 $1,019 · 2025 $1,041
Food & beverage: $1,027Education: $14
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $289 |
| Novo Nordisk Inc | 2 | $141 |
| Janssen Biotech, Inc. | 3 | $74 |
| GENZYME CORPORATION | 3 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
| Lilly USA, LLC | 2 | $61 |
| Madrigal Pharmaceuticals | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| PFIZER INC. | 2 | $42 |
Products named: RINVOQ, Wegovy, TREMFYA, DUPIXENT, XIFAXAN, OMVOH, CREON, REZDIFFRA.
Industry payments across MI — which companies pay providers there.
